Arthritis News - 1999

Lyme disease is a tick-borne infection caused by Borrelia burgdorferi. Manifestations include arthritis, cardiac effects, neurologic abnormalities, and secondary skin lesions.

Lymerix (recombinant OspA) is the first vaccine proven safe and effective in preventing both definite Lyme disease and asymptomatic infection. Lymerix protects by eliciting high levels of anti-OspA antibodies after injection. Following attachment by the tick to a human host, these antibodies enter the midgut of the tick and kill Borrelia burgdorferi, thereby preventing transmission.

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.